Smad3-dependent and-independent pathways are involved in peritoneal membrane injury

Kidney International

Volumn 77, Issue 4, 2010, Pages 319-328

  Patel, Pranali ^a   Sekiguchi, Yoshimi ^a   Oh, Kook Hwan ^b   Patterson, Sarah E ^a   Kolb, Martin R J ^a   Margetts, Peter J ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

^b Seoul National University Hospital   (South Korea)

Author keywords

Adenovirus; Angiogenesis; Fibrosis; MTOR; Peritoneum; Rapamycin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROSIS; GENE EXPRESSION; GENE TRANSFER; MEMBRANE DAMAGE; MESENCHYME; MESOTHELIUM CELL; MOUSE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UPREGULATION; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; EPITHELIAL CELLS; MESODERM; MICE; PERITONEAL FIBROSIS; PERITONEUM; SIGNAL TRANSDUCTION; SMAD3 PROTEIN;

EID: 75749091762     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.436     Document Type: Article

References (43)

1. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23: 530-541.
2. Brimble KS, Walker M, Margetts PJ et al. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2591-2598.
3. Margetts PJ, Bonniaud P, Liu L et al. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005; 16: 425-436.
4. Yanez-Mo M, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413. (Pubitemid 36159357)
5. Aroeira LS, Aguilera A, Sanchez-Tomero JA et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007; 18: 2004-2013.
6. Massague J. TGF-beta signal transduction. Annu Rev Biochem 2007; 67: 753-791.
7. Flanders KC, Sullivan CD, Fujii M et al. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 2002; 160: 1057-1068.
8. Sato M, Muragaki Y, Saika S et al. Targeted disruption of TGF-beta1/ Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112: 1486-1494.
9. Bonniaud P, Kolb M, Galt T et al. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 2004; 173: 2099-2108.
10. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001; 23: 912-923.
11. Zeisberg M, Bottiglio C, Kumar N et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 2003; 285: F1060-F1067.
12. Lin SL, Kisseleva T, Brenner DA et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617-1627.
13. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784.
14. Saika S, Kono-Saika S, Ohnishi Y et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol 2004; 164: 651-663.
15. Cho HJ, Baek KE, Saika S et al. Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 2007; 353: 337-343.
16. Shirai K, Saika S, Tanaka T et al. A new model of anterior subcapsular cataract: involvement of TGFbeta/Smad signaling. Mol Vis 2006; 12: 681-691.
17. Banh A, Deschamps PA, Gauldie J et al. Lens-specific expression of TGF-beta induces anterior subcapsular cataract formation in the absence of Smad3. Invest Ophthalmol Vis Sci 2006; 47: 3450-3460.
18. Cho HJ, Yoo J. Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int 2007; 31: 1225-1230.
19. Sebe A, Leivonen SK, Fintha A et al. Transforming growth factor-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38 mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial myofibroblast transdifferentiation. Nephrol Dial Transplant 2008; 23: 1537-1545.
20. Lamouille S, Derynck R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 2007; 178: 437-451.
21. Fujishita T, Aoki K, Lane HA et al. Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice. Proc Natl Acad Sci USA 2008; 105: 13544-13549.
22. Runyan CE, Schnaper HW, Poncelet AC. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 2004; 279: 2632-2639.
23. Jiang BH, Liu LZ. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 2008; 1784: 150-158.
24. Dong J, Peng J, Zhang H et al. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity. Cancer Res 2005; 65: 1961-1972.
25. Conacci-Sorrell M, Zhurinsky J, Ben Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987-991.
26. Zhang H, Sun L, Wang W et al. Quantitative analysis of fibrosis formation on the microcapsule surface with the use of picro-sirius red staining, polarized light microscopy, and digital image analysis. J Biomed Mater Res A 2006; 76: 120-125.
27. Carver EA, Jiang R, Lan Y et al. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol 2001; 21: 8184-8188.
28. Margetts PJ, Kolb M, Galt T et al. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001; 12: 2029-2039.
29. Valcourt U, Kowanetz M, Niimi H et al. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005; 16: 1987-2002.
30. Aguilera A, Aroeira LS, Ramirez-Huesca M et al. Effects of rapamycin on the epithelial-to-mesenchymal transition of human peritoneal mesothelial cells. Int J Artif Organs 2005; 28: 164-169.
31. Copeland JW, Beaumont BW, Merrilees MJ et al. Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation 2007; 83: 809-814.
32. LoPiccolo J, Granville CA, Gills JJ et al. Targeting Akt in cancer therapy. Anticancer Drugs 2007; 18: 861-874.
33. Zhang HH, Lipovsky AI, Dibble CC et al. S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol Cell 2006; 24: 185-197.
34. Luo J. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett 2009; 273: 194-200.
35. Inoki K, Ouyang H, Zhu T et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006; 126: 955-968.
36. Huang D, Du X. Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. World J Gastroenterol 2008; 14: 1823-1827.
37. Liu H, Remedi MS, Pappan KL et al. Glycogen synthase kinase-3 and mammalian target of rapamycin pathways contribute to DNA synthesis, cell cycle progression, and proliferation in human islets. Diabetes 2009; 58: 663-672.
38. Segrelles C, Moral M, Lara MF et al. Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 2006; 25: 1174-1185.
39. Yang X, Letterio JJ, Lechleider RJ et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999; 18: 1280-1291.
40. Clifford RL, Deacon K, Knox AJ. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta). J Biol Chem 2008; 283: 35337-35353.
41. Lloberas N, Cruzado JM, Franquesa M et al. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol 2006; 17: 1395-1404.
42. Wu MJ, Wen MC, Chiu YT et al. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int 2006; 69: 2029-2036.
43. Sime PJ, Xing Z, Graham FL et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100: 768-776.